pharma · Multiple Myeloma · Neoplasms
Teva/Actavis Generics
Teva Generics B.V
Teva Generics is a pharma organization headquartered in EU. Primary therapeutic focus areas include Multiple Myeloma, Neoplasms, Eosinophilic Asthma, Asthma. NovaPharmaNews links 4 clinical program(s), 0 drug profile(s),
Salt Lake City, USA HQ
1992 Founded
100 Employees
EMA registrant Type
Company details
- Status
- Public
- HQ
- Salt Lake City, USA
- Founded
- 1992
- Employees
- 100
- Programs
- 4
- Drugs
- 1
- Patents
- 0
Reslizumab
Phase 3 · small molecule · Eosinophilic Asthma
Reslizumab for Eosinophilic Asthma is a Phase 3 program (small_molecule) at Teva Generics B.V with 1 ClinicalTrials.gov record(s).
Internal code C38072/3085
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Teva Generics B.V
- Phase
- Phase 3
- Modality
- small_molecule
- Indication
- Eosinophilic Asthma
- Status
- terminated
- Trials
- 1